The Case for Tumor and Germline Testing in Endometrial Cancer Patients

A new study reinforces the need for universal mismatch repair protein immunohistochemistry screening of tumors from endometrial cancer patients, as well as germline genetic testing in accordance with guidelines.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news